Showing results (951-960 of 1,179) with videos related to

Sort By:
Pageof 118
Kidney Medicine|March 27, 2023
Serum Creatinine and Tacrolimus Assessment With VAMS Finger-Prick Microsampling: A Diagnostic Test StudyCarla E Scuderi, Suzanne L Parker, Margaret Jacks, et al.
Journal of Medical Internet Research|January 15, 2014
Skin self-examination education for early detection of melanoma: a randomized controlled trial of Internet, workbook, and in-person interventionsJune K Robinson, Rikki Gaber, Brittney Hultgren, et al.
The Cochrane Database of Systematic Reviews|October 2, 2024
Interventions for preventing the progression of autosomal dominant polycystic kidney diseaseKitty St Pierre, Brydee A Cashmore, Davide Bolignano, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 23, 2007
The impact of aprotinin on renal function after liver transplantation: an analysis of 1,043 patientsN Warnaar, S V Mallett, M T de Boer, et al.
BMC Nephrology|May 3, 2022
The prevalence of Fabry disease in a statewide chronic kidney disease cohort - Outcomes of the aCQuiRE (Ckd.Qld fabRy Epidemiology) studyAndrew Mallett, Phoebe Jane Kearey, Anne Cameron, et al.
The Lancet. Respiratory Medicine|February 3, 2022
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label studyRuvim Izikson, Daniel Brune, Jean-Sébastien Bolduc, et al.
Kidney International Reports|September 14, 2019
ADPedKD: A Global Online Platform on the Management of Children With ADPKDStéphanie De Rechter, Detlef Bockenhauer, Lisa M Guay-Woodford, et al.
BMJ Open|May 2, 2022
Imaging features for the prediction of clinical endpoints in chronic liver disease: a scoping review protocolManil D Chouhan, Stuart Andrew Taylor, Anisha Bhagwanani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1993
Rhenium-186-labeled chimeric antibody NR-LU-13: pharmacokinetics, biodistribution and immunogenicity relative to murine analog NR-LU-10P L Weiden, H B Breitz, C A Seiler, et al.
Internal Medicine Journal|August 7, 2015
Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohortA Mallett, P Hughes, J Szer, et al.
Pageof 118